s6y

OSIRIS THERAPEUTICS, INC.

CIK
1360886
Industry
Biological Products, (No Diagnostic Substances)

Financials 57

  1. 10-K Annual Report for period ending Dec 31, 2018
  2. 10-Q Quarterly Report for period ending Sep 30, 2018
  3. 10-Q Quarterly Report for period ending Jun 30, 2018
  4. 10-Q Quarterly Report for period ending Mar 31, 2018
  5. 10-K Annual Report for period ending Dec 31, 2017
  6. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2017
  7. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2017
  8. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2017
  9. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2017
  10. 10-K/A Annual Report for period ending Dec 31, 2014

All 57 financials filings

News 159

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 159 news filings

Ownership 223

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. SC 13D/A Major Shareholders
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 223 ownership filings

Prospectus 26

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. SC TO-T/A Third party tender offer statement
  7. SC TO-T/A Third party tender offer statement
  8. SC TO-T/A Third party tender offer statement
  9. SC TO-T/A Third party tender offer statement
  10. SC TO-T Third party tender offer statement

All 26 prospectus filings

Proxies 24

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 24 proxies filings

Other 48

  1. 15-12B Notice of termination of registration of a class of securities under Section 12(b)
  2. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  3. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  4. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  5. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  6. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  7. SC 14D9 Tender offer solicitation/recommendation statements filed under Rule 14d-9
  8. SC14D9C Written communication by the subject company relating to a third party tender offer
  9. SC14D9C Written communication by the subject company relating to a third party tender offer
  10. CERT Certification by an exchange approving securities for listing

All 48 other filings